Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pruneri

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Histopathology|June 1, 1996
p53 protein expression in laryngeal squamous cell carcinomas bearing wild-type and mutated p53 geneG Pruneri, L Pignataro, N S Fracchiolla, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|October 25, 2012
Metastasis to the right stellate ganglion and vagal nerve: pathological alterations causing sudden death. A case reportF Maffini, G Pruneri, N Colombo, et al.
The Prostate|February 18, 1998
Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapyG Pruneri, S Galli, R S Rossi, et al.
International Journal of Cancer|December 18, 2001
Immunoreactivity for p27(KIP1) and cyclin E is an independent predictor of survival in primary gastric non-Hodgkin's lymphomaA J Ferreri, M Ponzoni, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trialsS Gandini, A Guerrieri-Gonzaga, G Pruneri, et al.
British Journal of Haematology|May 19, 2004
ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysisG Martinelli, E Cocorocchio, F Peccatori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Breast (Edinburgh, Scotland)|January 26, 2013
Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodesM Saghatchian, S Mook, G Pruneri, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2009
Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trialS Mook, H Bonnefoi, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2012
Outcome and clinical-biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastasesE Munzone, E Botteri, A Esposito, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Histopathology|June 1, 1996
p53 protein expression in laryngeal squamous cell carcinomas bearing wild-type and mutated p53 geneG Pruneri, L Pignataro, N S Fracchiolla, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|October 25, 2012
Metastasis to the right stellate ganglion and vagal nerve: pathological alterations causing sudden death. A case reportF Maffini, G Pruneri, N Colombo, et al.
The Prostate|February 18, 1998
Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapyG Pruneri, S Galli, R S Rossi, et al.
International Journal of Cancer|December 18, 2001
Immunoreactivity for p27(KIP1) and cyclin E is an independent predictor of survival in primary gastric non-Hodgkin's lymphomaA J Ferreri, M Ponzoni, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trialsS Gandini, A Guerrieri-Gonzaga, G Pruneri, et al.
British Journal of Haematology|May 19, 2004
ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysisG Martinelli, E Cocorocchio, F Peccatori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Breast (Edinburgh, Scotland)|January 26, 2013
Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodesM Saghatchian, S Mook, G Pruneri, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2009
Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trialS Mook, H Bonnefoi, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2012
Outcome and clinical-biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastasesE Munzone, E Botteri, A Esposito, et al.
Pageof 11